Gabriela Vilema Enríquez, PhD
After completing her undergraduate programme in Biotechnology engineering in Quito, Ecuador, Gabriela moved to the Sorbonne University, Paris for her Master’s in Cellular and Molecular Biology. She then joined the University of Oxford where she obtained a PhD studying the epigenetic mechanisms behind the silencing of the frataxin gene in Friedreich’s Ataxia. She stayed in the Richard Wade-Martins’ group for her postdoc where she developed her Ataxia findings in more relevant cells models such as iPSC-derived sensory neurons. She joins Samsara Therapeutics to strengthen the disease modelling team and work utilising iPSCs to derive several neuronal types, a key step in our drug discovery pipeline.